Thermo Fisher (NYSE:TMO) Gets Some Love from Jefferies (NYSE:JEF)

Citing improving conditions in capital equipment markets and more stability in their cash flow streams, Jefferies (NYSE:JEF) is a little more bullish on Thermo Fisher Scientific (NYSE:TMO) than they have been.

Jefferies stated, "TMO's status as a highly-diversified, vertically-integrated life science and healthcare products franchise leverages it to rebounding conditions in capital equipment markets, while limiting the volatility of its cash flow stream. Recent capital re-deployment clarity should increase its appeal to a broader universe of investors, in our view."

EPS and revenue estimates for Thermo Fisher were maintained for Full year 2010,11,12, at $3.50/$10.8 billion, $3.90/$11.5 billion, and $4.15/$12.1 billion.

Jefferies maintains their "Buy" rating on Thermo Fisher Scientific, which closed Tuesday at $55.11, down $0.45, or 0.81 percent. They lowered their price target on them from $65 to $64.